Compare NEOS S&P 500 High Income ETF (SPYI) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NEOS S&P 500 High Income ETF vs Zoetis Inc — how do they compare? NEOS S&P 500 High Income ETF trades at $54.09 (market cap $12.50B), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Zoetis Inc is far larger — about 2.4× NEOS S&P 500 High Income ETF's market cap, and Zoetis Inc pays a 2.9% dividend while NEOS S&P 500 High Income ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold NEOS S&P 500 High Income ETF for 58 Days and Zoetis Inc for 70 Days on average.
| SPYI | ZTS | |
|---|---|---|
Market Cap | $12.50B | $30.20B |
Volume | 3,058,962 | 6,175,327 |
Sector | Income / Options Overlay | Health |
52-Week High | $54.42 | $147.53 |
52-Week Low | $47.98 | $69.09 |
Typical Hold Time | 58 Days | 70 Days |
Enterprise Value | — | $37.76B |
Dividend Yield | — | 2.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SPYI trades at $54.09 with a slight 0.15% daily gain, showing modest upward momentum amid bullish technical signals. The ETF maintains a strong income focus with recent monthly dividends around $0.53-0.54, though key valuation metrics remain unavailable. Technical analysis indicates bullish moving averages but neutral oscillators, with RSI-6 suggesting potential overbought conditions at 72.22.
SPYI offers high-income generation through covered call strategies but faces principal erosion risks as highlighted in recent analysis. The ETF's 12% yield attracts retirement investors, though coverage warns of potential capital depletion with systematic withdrawals. Market sentiment remains mixed between income appeal and long-term growth concerns.
Zoetis (ZTS) trades at $73.08, up 2.14% today, with a bullish technical signal but mixed earnings history including a recent Q1 2026 miss. The stock shows strong profitability with a 27.69% net income margin and 64.91% ROE, while valuation metrics like a P/E of 11.92 appear reasonable. Recent news highlights competitive pressures in the U.S. pet care market, though international segments remain resilient.
The outlook is cautiously optimistic; ZTS faces near-term headwinds from weak U.S. demand and competition, but its industry-leading margins and dominant market position support long-term growth. Risks include pricing erosion and guidance cuts, yet the consensus price target of $87.33 suggests upside potential for patient investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About NEOS S&P 500 High Income ETF
SPYI is an actively managed ETF designed to generate high monthly income through a data-driven call option strategy on the S&P 500 Index. Unlike traditional covered call funds that often forfeit significant upside, SPYI utilizes a 'call spread' approach—selling near-the-money calls while buying out-of-the-money calls—to capture a portion of equity appreciation in rising markets. It prioritizes tax efficiency by utilizing Section 1256 contracts and tax-loss harvesting to provide investors with high-yield monthly distributions.
Read more on SPYI →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
